Current Price – $95.4
Tender Price – TBD
Upside – TBD
Expiration Date – Q2 2018
This potential upcoming opportunity was highlighted by Sean.
Herbalife intends to launch tender offer to repurchase $450m-$600m of stock. Tender prices have not been announced yet, but some might be interested in trading this on the basis of how 2017 Aug tender offer worked out.
2017 August Tender
– Announced on 21st of August 2017. Document here.
– Terms: $600m at $60-$68/per share.
– Pre-announcement price $62.
– Post announcement price $68.
– Price at tender expiration $67.6.
– Offer ended up under-subscribed and only $458m worth of stock was repurchased at $68.
– After tender results were announced share price shot up to $75.25.
– There was odd-lot provision as well.
So there is a way to play this before the tender announcement with expectation that share price will again shoot up closer to the upper limit. This tender offer does not really open any additional opportunities for the larger shareholders to liquidate – e.g. yesterday’s volume was almost $200m or 1/3 of the current tender allocation, so larger shareholders do not really need tender offer to be able to exit.
– Exposure to ST price movement before the tender details are announced.
– Uncertain timing – press release says the transaction will be completed in Q2 2018. Most likely tender details will already be announced in March.
– Share price has already run up from $87 to $97 post the announcement (quite likely in the anticipation of above tender dynamics and continued short squeeze).